ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,568Medicare Part D Prescriptions Filled, Including Refills

Rank: 88 out of 315

$362K Total Retail Price of All Prescriptions

Rank: 123 out of 315

632 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
8% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 632 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

7% of this provider’s 632 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 5,991 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

10 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
SIMVASTATIN 620 595 1 1
LISINOPRIL 386 374 2 3
ATENOLOL 219 214 3 11
OXYCODONE HCL 200 94 S2 4 57
AMLODIPINE BESYLATE 197 186 5 2
LOSARTAN POTASSIUM 195 188 6 4
WARFARIN SODIUM 146 143 7 20
HYDROCODONE-ACETAMINOPHEN 137 133 S3 8 19
GLIPIZIDE 133 126 9 30
HYDROCHLOROTHIAZIDE 132 125 10 16
METOPROLOL TARTRATE 122 117 11 18
LEVOTHROID 118 116 12 61
LEVOTHYROXINE SODIUM 108 104 13 6
ATORVASTATIN CALCIUM 102 101 14 5
NOVOLIN N 95 95 15 96
ALENDRONATE SODIUM 95 94 15 12
METFORMIN HCL 93 88 17 7
PRAVASTATIN SODIUM 90 88 18 10
GABAPENTIN 87 79 19 37
FLUTICASONE PROPIONATE 84 75 20 53
MELOXICAM 75 72 21 77
INSULIN SYRINGE 71 71 22 79
ZOLPIDEM TARTRATE 69 63 23 29
OXYCODONE-ACETAMINOPHEN 68 58 S2 24 112
K-TAB 66 62 25 101
FUROSEMIDE 65 63 26 15
PROAIR HFA 64 61 27 52
DIGOXIN 63 63 28 45
CEPHALEXIN 63 61 28 109
TRIAMTERENE-HYDROCHLOROTHIAZID 60 60 30 140
CITALOPRAM HBR 54 54 31 72
QVAR 53 50 32 144
PREDNISONE 53 50 32 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 10, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.